Leaflet VENLAFAXINA TERAPIA 150mg prolonged release capsules


Indicated for: depression; anxiety disorders

Substance: venlafaxine (serotonin-norepinephrine reuptake inhibitor)

ATC: N06AX16 (Nervous system | Antidepressants | Other antidepressants)

Venlafaxine is a medication used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. It belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs), working by increasing the levels of these neurotransmitters in the brain, which helps regulate mood and reduce anxiety symptoms.

Venlafaxine is usually taken once daily as extended-release tablets and can be taken with or without food. The dosage is gradually adjusted based on the patient's response and tolerance.

Common side effects include nausea, dizziness, dry mouth, insomnia, excessive sweating, and loss of appetite. In some cases, it may cause an increase in blood pressure, so regular monitoring is necessary.

It is important not to stop venlafaxine treatment abruptly, as this can lead to withdrawal symptoms such as irritability, dizziness, or sleep disturbances. Patients should strictly follow their doctor's recommendations and discuss any side effects or concerns.

General data about VENLAFAXINA TERAPIA 150mg

  • Substance: venlafaxine
  • Date of last drug list: 01-07-2017
  • Commercial code: W59166004
  • Concentration: 150mg
  • Pharmaceutical form: prolonged release capsules
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for venlafaxine

Concentrations available for venlafaxine

  • 150mg
  • 25mg
  • 37.5mg
  • 50mg
  • 75mg